By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
EXPAREL143.27M80.77%
ZILRETTA26.77M15.09%
iovera°6.18M3.48%
Bupivacaine liposome injectable suspension1.16M0.65%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States722.85M99.51%
Royalty revenue3.56M0.49%